Clinical trial

Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2

NCT01827735

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-03-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2013-03-01Date precision: month

Registry last updated2015-06-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

Aldesleukin (Proleukin)DRUG

Sponsors & collaborators

Cambridge University Hospitals NHS Foundation Trustlead sponsor

University of Cambridgecollaborator

Juvenile Diabetes Research Foundationcollaborator

National Institute for Health Research, United Kingdomcollaborator

Wellcome Trustcollaborator

Mapped research locations

CambridgeUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01827735 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.